232 filings
Page 3 of 12
8-K
hthu0yj80s
3 Sep 20
Entry into a Material Definitive Agreement
8:37am
8-K
5nkgzgua
4 Aug 20
Idera Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update
4:31pm
8-K
tl8 q956fv3idzcyto
15 Jul 20
Idera Pharmaceuticals Announces Private Placement of up to $20.0 Million
8:15am
8-K
l1se6 kkxd
15 Jun 20
Departure of Directors or Certain Officers
4:31pm
8-K
ciqotlfrsz 93bsj8w8
2 Jun 20
Regulation FD Disclosure
8:33am
8-K
84ylra
18 May 20
Other Events
8:00am
8-K
uk8f0si1
14 May 20
Submission of Matters to a Vote of Security Holders
8:00am
8-K
k2d53jhzmrt1s2
1 May 20
Idera Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
8:10am
8-K
b3v3el42o
21 Apr 20
Idera Pharmaceuticals Announces Final Clinical Safety and Efficacy Data from ILLUMINATE-204 Trial in Advanced Melanoma
8:00am
8-K
sg09m34fske3w1eg2
7 Apr 20
Idera Pharmaceuticals Announces Private Placement of up to $20.7 Million
4:30pm
8-K
4mqgqnp dep4
12 Mar 20
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
7:49am
8-K
c09ry in3m
5 Mar 20
Regulation FD Disclosure
8:00am
8-K
5col9dh2dwj j31d4y
27 Jan 20
Departure of Directors or Certain Officers
5:10pm
8-K
u83 qdenkki4
15 Jan 20
38 th Annual JP Morgan Healthcare Conference
7:05am
8-K
v1zw1iw
14 Jan 20
Regulation FD Disclosure
7:05am
8-K
kxgqkzq2
23 Dec 19
Idera Pharmaceuticals Announces Private Placement Up To $97.7 Million
4:01pm
8-K
mhi0pjpo8k
6 Nov 19
Idera Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2019 Financial Results
4:13pm
8-K
lbpl2a8q
31 Oct 19
October 2019 Corporate Update
5:14pm
8-K
3m0u9bvp huwwxudz
4 Sep 19
Idera Pharmaceuticals Announces Immuno-Oncology Clinical Research Collaboration with AbbVie
7:05am
8-K
k7dxsav7
29 Aug 19
Regulation FD Disclosure
4:03pm